Top BOD with Halyk & Martin (former CEO of Nestle Canada)!!! It's a long play for me now at these silly low share price!
Lately it received a cannabis drug license so it can now manufacture a medical drug with a DIN.
It can now apply that license to its white label and manufacture medication for companies.
Pharmaceutical giant Stada and the five-year partnership in Germany has already started!
Australia has gone OTC on CBD. Great for the Australian facility, and being able to ship to the EU to fulfill contracts.
Canadian facility recorded 555,000 units inQ4.
Also, a rather very competent BOD with the addition of Chris Halyk of Johnson &Johnson / Janssen and Shelly Martin, former president & CEO of Nestle Canada.
Let´s hope that they find the right CEO, someone that will help them expand into the international pharmaceutical market.
PS: I'm sceptical about how investors will react to Q4 and Q1 earnings, however I do feel good about my investement in Mediparm in the long run.
PPS: I shall keep ready to deploy even more "dry powder" when the stock gets further down after Q4 and Q1 earnings.